Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-24 @ 5:06 PM
NCT ID:
NCT03246750
Eligibility Criteria:
Inclusion Criteria:
* Patients with previously untreated ENKTL as defined by the World Health Organization (WHO) classification
* Age 18-60 years
* Localized (stage I, II) or advanced (stage III, IV) disease
* Adequate organ function
* Signed informed consent
Exclusion Criteria:
* Patients with other subtypes of non-Hodgkin lymphoma, including myeloid/NK cell precursor acute leukemia, blastic NK cell lymphoma/precursor NK cell lymphoblastic leukemia, aggressive NK cell leukemia, and peripheral T cell lymphoma, unspecified
* Prior chemotherapy or radiotherapy for ENKTL
* Seropositivity for HIV and severe infection
* Prior or other concomitant malignant tumors
* Pregnant or breastfeeding patients
* Evidence of any other disease or medical conditions that contraindicate use of the study drug, or patients at high risk from treatment complications
* Patients suffering from psychiatric disorders
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT03246750
Study Brief:
Protocol Section:
NCT03246750